
MISSED BY OTHERS, DETECTED BY US
Genomic Unity® 2.0 Case Study
Clinical presentation
A 7-month-old female with a history of premature birth and small size for gestational age presented with the following symptoms:
- Hypotonia
- Failure to thrive
- Developmental delay
Previous genetic testing
Prader-Willi syndrome was suspected, however multiple tests were performed with negative results including:
- FISH for Prader-Willi/Angelman syndrome
- Mitochondrial genome sequencing
- Whole exome sequencing

Genomic Unity® Testing
was ordered because of its ability to identify all major variant types in a single test.
Genomic Unity® Testing
Variantyx Genomic Unity® testing identified maternal, partial UPiD of ~42Mb at 15q11.2q22.31 and maternal, partial UPhD of ~36Mb at 15q22.31q26.3.
MAGEL2 and SNURF regions are normally paternally expressed, but show extra methylation consistent with maternal UPD.
Diagnosis: Prader-Willi syndrome

Genomic Unity® 2.0 long-read sequencing makes it possible to identify aberrant Chr15 methylation.
The Variantyx Difference
Why was Genomic Unity® testing able to identify the presence of uniparental disomy and hypermethylation that was missed by other tests?
-
Uniparental disomy is not readily detected by FISH or exome sequencing.
Variantyx genome analysis detects all major variant types in a single test including small sequence changes, mitochondrial variants, repeat expansions and structural variants. It easily detected the uniparental disomy while simultaneously ruling out other variant types. -
Methylation status can not be detected by FISH or exome sequencing.
With dual short and long-read sequencing, Genomic Unity® 2.0 enables methylation analysis of the chromosome 15 region associated with Prader-Willi syndrome.
Variantyx tests that would have identified this variant
*While all of these tests would have identified the uniparental disomy, only Genomic Unity® 2.0 would provide the additional methylation pattern data.
Want similar results for your patients?
Connect with a Clinical Specialist to find out how easy it is to bring the power of whole genome sequencing into your practice.